Syndax Pharmaceuticals Inc Lessee, Operating Lease, Liability, to be Paid in USD from Q4 2018 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Syndax Pharmaceuticals Inc quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q4 2018 to Q4 2024.
  • Syndax Pharmaceuticals Inc Lessee, Operating Lease, Liability, to be Paid for the quarter ending December 31, 2024 was $2.45M, a 35.8% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)

Syndax Pharmaceuticals Inc Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $2.45M +$646K +35.8% Dec 31, 2024 10-K 2025-03-03
Q4 2023 $1.8M +$451K +33.4% Dec 31, 2023 10-K 2024-02-27
Q4 2022 $1.35M +$48K +3.68% Dec 31, 2022 10-K 2023-02-28
Q4 2021 $1.3M +$850K +188% Dec 31, 2021 10-K 2022-03-01
Q4 2020 $453K -$585K -56.4% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $1.04M -$573K -35.6% Dec 31, 2019 10-K 2021-03-12
Q3 2019 $1.18M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $1.32M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $1.47M Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $1.61M Dec 31, 2018 10-K 2020-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.